Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09VAZ
|
||||
| Former ID |
DNC011083
|
||||
| Drug Name |
TRIENTINE
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Inborn error of metabolism [ICD10:E88.9] | Approved | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C6H19ClN4
|
||||
| Canonical SMILES |
C(CNCCNCCN)N
|
||||
| InChI |
1S/C6H18N4/c7-1-3-9-5-6-10-4-2-8/h9-10H,1-8H2
|
||||
| InChIKey |
VILCJCGEZXAXTO-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Carbonic anhydrase XIV | Target Info | Inhibitor | [2] | |
| KEGG Pathway | Nitrogen metabolism | ||||
| Reactome | Reversible hydration of carbon dioxide | ||||
| WikiPathways | Reversible Hydration of Carbon Dioxide | ||||
| References | |||||
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
| REF 2 | J Med Chem. 2010 Aug 12;53(15):5511-22.Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.